BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8060438)

  • 1. Surveillance, prevention and control of drug abuse in hospitals.
    Galarza NJ
    Bol Asoc Med P R; 1993; 85(1-3):18-20. PubMed ID: 8060438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community-based prevention of substance abuse.
    De La Haye W
    West Indian Med J; 2004 Dec; 53(6):420-3. PubMed ID: 15816272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National addictions vigilance intervention and prevention program (NAVIPPRO): a real-time, product-specific, public health surveillance system for monitoring prescription drug abuse.
    Butler SF; Budman SH; Licari A; Cassidy TA; Lioy K; Dickinson J; Brownstein JS; Benneyan JC; Green TC; Katz N
    Pharmacoepidemiol Drug Saf; 2008 Dec; 17(12):1142-54. PubMed ID: 18932173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substance abuse and mandatory drug testing in health care institutions.
    Tanner J; Kinard J; Cappel S; Wright P
    Health Care Manage Rev; 1988; 13(4):33-42. PubMed ID: 3230007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishing a substance abuse treatment program: considerations for the administrator.
    Cottler LB; Lyndly J
    Hosp Health Serv Adm; 1992; 37(2):237-45. PubMed ID: 10171003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substance abuse in the Republic of Croatia and National Program for Drug Control.
    Sakoman S
    Croat Med J; 2000 Sep; 41(3):270-86. PubMed ID: 10962046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development of a comprehensive risk-management program for prescription opioid analgesics: researched abuse, diversion and addiction-related surveillance (RADARS).
    Cicero TJ; Dart RC; Inciardi JA; Woody GE; Schnoll S; Muñoz A
    Pain Med; 2007 Mar; 8(2):157-70. PubMed ID: 17305687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substance abuse: new numbers are a cause for action.
    Kehoe WA
    Ann Pharmacother; 2008 Feb; 42(2):270-2. PubMed ID: 18198240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managed care, networks and trends in hospital care for mental health and substance abuse treatment in Massachusetts: 1994-1999.
    Fleming E; Lien H; Ma CT; McGuire TG
    J Ment Health Policy Econ; 2003 Mar; 6(1):3-12. PubMed ID: 14578543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inpatient stays for patients diagnosed with severe psychiatric disorders and substance abuse.
    Bradley CJ; Zarkin GA
    Health Serv Res; 1996 Oct; 31(4):387-408. PubMed ID: 8885855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fighting drug abuse in operating rooms.
    Nemes J
    Mod Healthc; 1991 Jul; 21(30):60, 62. PubMed ID: 10170762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are clinical impressions of adolescent substance use accurate?
    Wilson CR; Sherritt L; Gates E; Knight JR
    Pediatrics; 2004 Nov; 114(5):e536-40. PubMed ID: 15520086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Under pressure program: using live theatre to investigate adolescents' attitudes and behavior related to drug and alcohol abuse education and prevention.
    Safer LA; Harding CG
    Adolescence; 1993; 28(109):135-48. PubMed ID: 8456602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment for substance abuse in Australia: a comparison of public and private programs.
    McNeese-Smith DK
    Int J Psychiatr Nurs Res; 2003 Sep; 9(1):1025-38. PubMed ID: 14533233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A strategy to prevent substance abuse in an academic anesthesiology department.
    Tetzlaff J; Collins GB; Brown DL; Leak BC; Pollock G; Popa D
    J Clin Anesth; 2010 Mar; 22(2):143-50. PubMed ID: 20304360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substance abuse prevention infrastructure: a survey-based study of the organizational structure and function of the D.A.R.E. program.
    Merrill JC; Pinsky I; Killeya-Jones LA; Sloboda Z; Dilascio T
    Subst Abuse Treat Prev Policy; 2006 Sep; 1():25. PubMed ID: 16956400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National Drugs Campaign--the GP's role in reducing illicit drug use.
    Winstock A
    Aust Fam Physician; 2006 Mar; 35(3):121-3. PubMed ID: 16525524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substance abuse in the workplace: creating a responsible policy.
    Tamborini-Martin S; Vachon DO; Hanley KV
    Health Prog; 1988 Nov; 69(9):30-5. PubMed ID: 10318148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The challenge for women with a drug-abusing family member: the Jamaican perspective.
    Boyce-Reid K
    Bull Narc; 1995; 47(1-2):23-30. PubMed ID: 8904657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A supervisor's role in workplace drug abuse.
    Mazzoni J
    Health Care Superv; 1990 Jan; 8(2):35-9. PubMed ID: 10170491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.